Go To Global Site
Welcome to UCB in the United States

Newsroom

Spotlight Story

UCB Community Health Fund: Supporting Vulnerable Populations Today and in the Future

Since the beginning of the global COVID-19 crisis, our focus has been on patients, our employees, supporting our communities, as well as the healthcare staff working on the frontlines. 

 

 

UCB U.S. News

UCB Achieves Important Regulatory Milestone for Bimekizumab

Read More

Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published…

Read More

Improving Diversity in Dermatology

Read More

Twitter Feed

For More Information